Derivation and validation of a simple clinical bedside score (ATLAS) for Clostridium difficile infection which predicts response to therapy
Open Access
- 25 March 2013
- journal article
- research article
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 13 (1), 148
- https://doi.org/10.1186/1471-2334-13-148
Abstract
Clostridium difficile infection (CDI) continues to be a frequent and potentially severe infection. There is currently no validated clinical tool for use at the time of CDI diagnosis to categorize patients in order to predict response to therapy.Keywords
This publication has 21 references indexed in Scilit:
- Fidaxomicin versus Vancomycin forClostridium difficileInfectionNew England Journal of Medicine, 2011
- Treatment with Monoclonal Antibodies againstClostridium difficileToxinsNew England Journal of Medicine, 2010
- National point prevalence of Clostridium difficile in US health care facility inpatients, 2008American Journal of Infection Control, 2009
- Emergence ofClostridium difficileInfection Due to a New Hypervirulent Strain, Polymerase Chain Reaction Ribotype 078Clinical Infectious Diseases, 2008
- Outcome of metronidazole therapy for Clostridium difficile disease and correlation with a scoring systemJournal of Infection, 2007
- A Comparison of Vancomycin and Metronidazole for the Treatment of Clostridium difficile-Associated Diarrhea, Stratified by Disease SeverityClinical Infectious Diseases, 2007
- A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and MortalityNew England Journal of Medicine, 2005
- Clostridium difficile toxoid vaccine in recurrent C. difficile-associated diarrheaGastroenterology, 2005
- A Hospital Outbreak of Clostridium difficile Disease Associated with Isolates Carrying Binary Toxin GenesClinical Infectious Diseases, 2005
- Severe Clostridium difficile colitisDiseases of the Colon & Rectum, 1995